|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 142.50 GBX | -0.70% |
|
-2.40% | +11.33% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 121M 162M 142M 131M 229M 15.44B 233M 1.56B 613M 7.61B 608M 595M 26.15B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 113M 152M 133M 122M 214M 14.46B 218M 1.46B 574M 7.12B 569M 557M 24.48B | EV / Sales 2026 * |
2.4x | EV / Sales 2027 * | 1.93x |
| Free-Float |
71.37% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Diaceutics PLC
| 1 day | -0.70% | ||
| 1 week | -2.40% | ||
| Current month | -2.40% | ||
| 3 months | -11.76% | ||
| Current year | +11.33% |
| 1 week | 142 |  | 148 |
| 1 month | 142 | | 150 |
| Current year | 125 | | 180 |
| 1 year | 114 | | 180 |
| 3 years | 82 | | 180 |
| 5 years | 74 | | 180 |
| 10 years | 74 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryan Keeling
CEO | Chief Executive Officer | 42 | 31/12/2023 |
Nick Roberts
DFI | Director of Finance/CFO | - | 17/03/2022 |
Kerri Donaldson
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Keeling
CHM | Chairman | 65 | 30/09/2024 |
Ryan Keeling
BRD | Director/Board Member | 42 | - |
Jordan Clark
BRD | Director/Board Member | 42 | 30/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-04 | Buy | Chief Financial Officer | 90 | 0.0001% | ||
| 05-04 | Free | Chief Financial Officer | 90 | 0.0001% | ||
| 05-04 | Free | Executive/Senior Manager | 89 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.70% | -2.40% | +19.75% | +67.65% | 162M | |
| +1.60% | +1.87% | +395.82% | +1,059.71% | 56.24B | |
| -6.56% | +5.05% | - | - | 6.66B | |
| +0.84% | -4.87% | +32.49% | +27.83% | 4.02B | |
| +3.69% | +0.44% | +12.49% | +111.23% | 3.22B | |
| +0.63% | +4.79% | -19.77% | -42.12% | 1.28B | |
| +1.70% | +2.84% | -28.32% | -45.49% | 1.28B | |
| +5.91% | +1.37% | -38.02% | +33.13% | 1.25B | |
| -1.04% | -1.86% | +27.35% | +239.29% | 1.21B | |
| Average | +0.67% | +2.59% | +50.22% | +181.40% | 8.37B | |
| Weighted average by Cap. | +0.94% | +2.24% | +325.66% | +878.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47M 63.08M 55.17M 50.89M 89.18M 6.02B 90.68M 608M 239M 2.96B 237M 232M 10.19B | 56.31M 75.57M 66.1M 60.97M 107M 7.21B 109M 729M 286M 3.55B 284M 278M 12.21B |
| Net income | -1.1M -1.48M -1.29M -1.19M -2.09M -141M -2.12M -14.23M -5.59M -69.36M -5.54M -5.42M -238M | 1.5M 2.01M 1.76M 1.62M 2.85M 192M 2.89M 19.4M 7.62M 94.58M 7.56M 7.39M 325M |
| Net Debt | -7.71M -10.35M -9.05M -8.35M -14.63M -987M -14.88M -99.74M -39.17M -486M -38.85M -38M -1.67B | -12.14M -16.29M -14.25M -13.14M -23.03M -1.55B -23.41M -157M -61.65M -765M -61.15M -59.82M -2.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | GBX 142.50 | -0.70% | 17,260 |
| 09/07/26 | GBX 143.50 | 0.00% | 8,314 |
| 08/07/26 | GBX 143.50 | -1.71% | 51,055 |
| 07/07/26 | GBX 146.00 | -0.34% | 54,312 |
| 06/07/26 | GBX 146.50 | +0.34% | 15,920 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DXRX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition